Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

0(0%)

Results Posted

100%(2 trials)

Phase Distribution

Ph phase_1

67%

Ph early_phase_1

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Early Phase 1First-in-human

1(33.3%)

Phase 1Safety & dosage

2(66.7%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(2)

Other(1)

Detailed Status

Completed2

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Early Phase 1

Trials by Phase

Early Phase 11 (33.3%)

Phase 12 (66.7%)

Trials by Status

completed267%

unknown133%

Recent Activity

0 active trials

Showing 3 of 3

unknownearly_phase_1

Novel Light Delivery Methods for Lung Cancer Photodynamic Therapy - A Pilot Study

NCT04753918

completedphase_1

Feasibility Study of Using Navigational Bronchoscopy to Perform PDT-Photofrin® in Unresectable Peripheral Lung Cancer

NCT02916745

completedphase_1

Safety of PDT-Photofrin® Prior to Lung Surgery

NCT03344861

Clinical Trials (3)

Showing 3 of 3 trials

NCT04753918Early Phase 1

Novel Light Delivery Methods for Lung Cancer Photodynamic Therapy - A Pilot Study

Unknown

NCT02916745Phase 1

Feasibility Study of Using Navigational Bronchoscopy to Perform PDT-Photofrin® in Unresectable Peripheral Lung Cancer

Completed

NCT03344861Phase 1

Safety of PDT-Photofrin® Prior to Lung Surgery

Completed

All 3 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 3